The data reported here demonstrate that a preparation extracted from nonpathogenic mycobacteria such as Mycobacterium smegmatis and hereafter referred to as interphase material protected mice against Ehrlich ascitic carcinoma, L-1210 leukemia, and another syngeneic lymphoid leukemia. Furthermore, mice treated by this preparation were much less susceptible to endotoxins than when stimulated by BCG (bacillus Calmette-Guerin) or M. smegmatis cells. Moreover, guinea pigs treated by interphase material administered in Freund's incomplete adjuvant showed an increased immune response, yet their sensitivity to tuberculin was much weaker than that of controls sensitized with Freund's complete adjuvant.
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Finally, resistance to Columbia SK virus infection could be demonstrated when interphase material was administered to mice prior to virus challenge.
It is now well established that mycobacteria have the ability to stimulate the immunity of the host against tumors (1) (2) . However, these organisms have also the capacity for rendering mice very susceptible to endotoxins (13) and for inducing delayed hypersensitivity to tuberculin. Our previous studies have shown that delipidated cells as well as purified cell walls of Mycobacterium smegmatis or M. kansasii had greater antitumor activity than killed cells of bacillus Calmette-Guerin (BCG), although they were devoid of several of the noxious effects of whole mycobacterial cells (14) .
In the following study various biological activities of a preparation extracted from nonpathogenic mycobacteria and hereafter referred to as interphase material (IPM) were evaluated.
MATERIALS AND the press with cooling. The resulting homogenate was centrifuged for 90 min at 5000 X g, yielding a multiphase system consisting of a lower cell debris layer, a lower opaque aqueous layer and an upper hexane layer containing a sedimented gelatinous phase. The aqueous phase was withdrawn from the system by aspiration and discarded. The hexane phase containing the gelatinous sediment was decanted and centrifuged at 10,000 X g for 1 hr. The gelatinous material was separated from the hexane by decantation, suspended in distilled water, and the suspension was freed from residual hexane by heating to about 380 under reduced pressure. The aqueous suspension was freeze-dried to yield 29 (14) . Antiviral Activity. Substances to be tested were suspended by sonication in polyethylene glycol 400. Groups of 30 mice (10 g body weight, Charles River CD-i strain) were inoculated either intraperitoneally or intravenously with the desired dose (10-100 mg/kg) of BCG or IPM and held for 14 days. At this time (day 0), 20 mice per group were challenged intraperitoneally with 20 LD50 (mean lethal dose) units of Columbia SK virus and the remaining 10 animals were sacrificed for measurement of spleen weights, 14 days after infection of test materials. Deaths were recorded daily, and the experiment was terminated at day 12. Deaths occurring before day 3 were excluded from the calculations. Mean survival time (MST) of untreated controls ranged from 4 to 5 days, and increase in MST was expressed as percentage increase compared to untreated controls. (16) .
Adjuvant Activity and Sensitivity to Tuberculin. Male Hartley guinea pigs of the Pasteur Institute strain weighing 350 g were injected in both hind footpads with 0.1 ml of a water-in-oil emulsion made of equal volumes of a saline solution of ovalbumin (50 mg/ml, egg albumin, five times crystallized, B grade, Calbiochem) and of either Freund's complete adjuvant or Freund's incomplete adjuvant (Difco). The mycobacterial fractions (2 mg/ml) were added to the antigen in the saline solution. All animals were skin-tested 18 days later with 100 IU or 300 IU of old tuberculin. The titers of circulating precipitins and agglutinins were also measured. RESULTS Leukemia L-1210 In each experiment, two control groups of 10 mice each received either diluent only or Pasteur strain BCG. Eight or 16 Further progress in understanding the mechanisms by which the host's resistance is increased by IPM will depend 
